Janelle Evans, MD
Urogynecology and Reconstructive Pelvic Surgery · Richmond, INNPI 1912058041
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,856 of the $4,609 with a category attached, or 62.0%. 14 manufacturers reported payments, led by Axonics, Inc. at 49.7% of the total. Reporting peaked in 2021 at $1,500 and has fallen 53.8% since, to $693 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in IN, where the typical reported total is $5,227.
Across 77 payments — averaging $59.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Stryker$700
- Medtronic$566
- Boston Scientific$293
- C. R. Bard, Inc. & Subsidiaries$179
- Coloplast$155
- plus $424 from 8 others
What the payments were for
- Consulting fees$70015%
- Travel & lodging$90220%
- Food & beverage$2,85662%
- Education$1513%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 33 | $2,292 |
| Stryker | 1 | $700 |
| Medtronic(2 entities) | 11 | $566 |
| Boston Scientific | 5 | $293 |
| C. R. Bard, Inc. & Subsidiaries | 10 | $179 |
| Coloplast | 2 | $155 |
| Smith+Nephew | 1 | $138 |
| Sumitomo Pharma America, Inc. | 6 | $122 |
| Contura, Inc. | 2 | $46 |
| Tolmar, Inc. | 2 | $31 |
| 180 Medical, Inc. | 1 | $27 |
| Urogen Pharma, Inc. | 1 | $26 |
| Calyxo, Inc. | 1 | $23 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics r-SNM System$1,399
- Bulkamid$1,261
- PHOTONBLADE$700
- Axonics$477
- INTERSTIM$242
- ALTIS$140
- PICO Single Use Negative Pressure Wound Therapy$138
How this compares
$4,609 in reported general payments places this provider in the 40th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Indiana.
See all urogynecology and reconstructive pelvic surgery providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 84 | $54,738 |
| GemtesaVibegron | 78 | $52,827 |
| Estradiol | 131 | $7,550 |
| Trimethoprim | 33 | $2,221 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 52 | $1,556 |
| Clobetasol Propionate | 15 | $238 |
| Gabapentin | 38 | $206 |
| Cephalexin | 16 | $184 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $180 |
| Ibuprofen | 34 | $103 |
| Methocarbamol | 17 | $21 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $19 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $122 | $52,82778 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Indiana.
Other urogynecology and reconstructive pelvic surgery in Richmond
- Sara Diaz ValentinRichmond$7K
- Cindy BasinskiNewburgh$132K
- Kathryn CopelandCarmel$26K
- Jeffrey BlakeNoblesville$15K
- Ted RothSouth Bend$14K
- Krystine GulbrandDanville$13K
- Hussein WardaGreenwood$10K
- Amanda LaporteIndianapolis$9K
- Martina MutoneFishers$7K
- Scott BoydFort Wayne$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.